Eva Nagy-Gannon

Calla emerged from the University of Galway following a two-year commercialization fund project funded by Enterprise Ireland. In August 2024, Calla received the Pre-Seed Start Fund and was also selected as a beneficiary of the Pre-Seed + programme through WestBIC. This programme provided invaluable support in key areas such as financial planning, fundraising, and go-to-market strategies. The support included both group sessions and personalized one-on-one meetings, tailored to our specific needs and progress.

For startups, understanding the different phases of your journey is crucial, knowing what each phase requires and how to leverage milestones to drive progress, particularly for ongoing fundraising. Instead of tackling everything at once, focus on filtering your endless to-do list down to a few key priorities and work towards achieving those.

The U.S. is our primary target market, driven by high breastfeeding rates and short maternity leave, making a breast pump an essential device. By 2029, we project €21 million in revenue with three breast pump models on the market. Currently, we are in the clinical trial phase and preparing for a seed funding round in Autumn 2025.